MiR-182-5p Mediated by Exosomes Derived From Bone Marrow Mesenchymal Stem Cell Attenuates Inflammatory Responses by Targeting TLR4 in a Mouse Model of Myocardial Infraction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Exosomes derived from mesenchymal stem cells (MSCs) could protect against myocardial infarction (MI). TLR4 is reported to play an important role in MI, while microRNA-182-5p (miR-182-5p) negatively regulates TLR4 expression. Therefore, we hypothesize that MSCs-derived exosomes overexpressing miR-182-5p may have beneficial effects on MI. We generated bone marrow mesenchymal stem cells (BM-MSCs) and overexpressed miR-182-5p in these cells for exosome isolation. H2O2-stimulated neonatal mouse ventricle myocytes (NMVMs) and MI mouse model were employed, which were subjected to exosome treatment. The expression of inflammatory factors, heart function, and TLR4 signaling pathway activation were monitored. It was found that miR-182-5p decreased TLR4 expression in BM-MSCs and NMVMs. Administration of exosomes overexpressing miR-182-5p to H2O2-stimulated NMVMs enhanced cell viability and suppressed the expression of inflammatory cytokines. In addition, they promoted heart function, suppressed inflammatory responses, and de-activated TLR4/NF-κB signaling pathway in MI mice. In conclusion, miR-182-5p transferred by the exosomes derived from BM-MSCs protected against MI-induced impairments by targeting TLR4.
Abstract
Exosomes derived from mesenchymal stem cells (MSCs) could protect against myocardial infarction (MI). TLR4 is reported to play an important role in MI, while microRNA-182-5p (miR-182-5p) negatively regulates TLR4 expression. Therefore, we hypothesize that MSCs-derived exosomes overexpressing miR-182-5p may have beneficial effects on MI. We generated bone marrow mesenchymal stem cells (BM-MSCs) and overexpressed miR-182-5p in these cells for exosome isolation. H2O2-stimulated neonatal mouse ventricle myocytes (NMVMs) and MI mouse model were employed, which were subjected to exosome treatment. The expression of inflammatory factors, heart function, and TLR4 signaling pathway activation were monitored. It was found that miR-182-5p decreased TLR4 expression in BM-MSCs and NMVMs. Administration of exosomes overexpressing miR-182-5p to H2O2-stimulated NMVMs enhanced cell viability and suppressed the expression of inflammatory cytokines. In addition, they promoted heart function, suppressed inflammatory responses, and de-activated TLR4/NF-κB signaling pathway in MI mice. In conclusion, miR-182-5p transferred by the exosomes derived from BM-MSCs protected against MI-induced impairments by targeting TLR4.
참고문헌 (39)
- Anderson JL, "Acute myocardial infarction", N Engl J Med, 376, pp.2053~2064 (2017)
- Chen Y, "MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction", Stem Cell Res Ther, 8, pp.268~ (2017)
- Sandor F, "Toll-like receptors. I. Structure, function and their ligands", Folia Biol(Praha), 51, pp.148~157 (2005)
- Frantz S, "Mechanisms of disease : Toll-like receptors in cardiovascular disease", Nat Clin Pract Cardiovasc Med, 4, pp.444~454 (2007)
- Yang Y, "The emerging role of Toll-like receptor 4 in myocardial inflammation", Cell Death Dis, 7, pp.e2234~ (2016)
- Liu L, "Up-regulated TLR4in cardiomyocytes exacerbates heart failure after long-term myocardial infarction", J Cell Mol Med, 19, pp.2728~2740 (2015)
- Shimamoto A, "Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemiareperfusion injury", Circulation, 114, pp.I270~I274 (2006)
- Ramirez-Carracedo R, "Targeting TLR4 with ApTOLL improves heart function in response to coronary ischemia reperfusion in pigs undergoing acute myocardial infarction", Biomolecules, 10, pp.1167~ (2020)
- Wang J, "MicroRNA-182-5p attenuates cerebral ischemia-reperfusion injury by targeting Toll-like receptor 4", Biochem Biophys Res Commun, 505, pp.677~684 (2018)
- Zhang J, "MicroRNA-182-5p alleviates spinal cord injury by inhibiting inflammation and apoptosis through modulating the TLR4", NF-κB pathway, 2018, pp.11, 2948~2958
- Zhu M, "MicroRNA-182-5p inhibits inflammation in LPS-treated RAW264. 7 cells by mediating the TLR4", NF-κB signaling pathway, 2018, pp.11, 5725~5734
- Jiang W, "Microrna-182-5p ameliorates liver ischemia-reperfusion injury by suppressing toll-like receptor 4", Transplant Proc, 48, pp.2809~2814 (2016)
- Müller P, "Stem cell therapy in heart diseases-cell types, mechanisms and improvement strategies", Cell Physiol Biochem, 48, pp.2607~2655 (2018)
- Psatha N, "Optimizing autologous cell grafts to improve stem cell gene therapy", Exp Hematol, 44, pp.528~539 (2016)
- Fu DL, "MicroRNA-338 in MSCs-derived exosomes inhibits cardiomyocyte apoptosis in myocardial infarction", Eur Rev Med Pharmacol Sci, 24, pp.10107~10117 (2020)
- Yuan MJ, "Exosomes mediate the intercellular communication after myocardial infarction", Int J Med Sci, 13, pp.113~116 (2016)
- Gallet R, "Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction", Eur Heart J, 38, pp.201~211 (2017)
- Song Y, "Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice", Cell Biol Toxicol, 37, pp.51~64 (2021)
- Zhang J, "Exosome and exosomal microRNA : trafficking, sorting, and function", Genomics Proteomics Bioinformatics, 13, pp.17~24 (2015)
- Li Y, "Bone marrow mesenchymal stem cells-derived exosomal microRNA-185 represses ventricular remolding of mice with myocardial infarction by inhibiting SOCS2", Int Immunopharmacol, 80, pp.106156~ (2020)
- Zhu H, "A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone", Nat Protoc, 5, pp.550~560 (2010)
- Jin J, "SRC3 expressed in bone marrow mesenchymal stem cells promotes the development of multiple myeloma", Acta Biochim Biophys Sin(Shanghai), 51, pp.1258~1266 (2019)
- Wu Z, "BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in mice", Int Immunopharmacol, 93, pp.107389~ (2021)
- Fan M, "Overexpression of the histidine triad nucleotide-binding protein 2 protects cardiac function in the adult mice after acute myocardial infarction", Acta Physiol(Oxf), 228, pp.e13439~ (2020)
- Wang K, "CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2downregulation", Nat Commun, 5, pp.3596~ (2014)
- Zhang A, "MicroRNA-182-5p relieves murine allergic rhinitis via TLR4", NF-κB pathway, 2020, pp.15, 1202~1212
- Hu X, "A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates : paracrine activity without remuscularization", Circ Res, 118, pp.970~983 (2016)
- Ji ST, "Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration : from cell priming to tissue engineering", Stem Cells Int, 2017, pp.3945403~ (2017)
- Guo Y, "The therapeutic potential of mesenchymal stem cells for cardiovascular diseases", Cell Death Dis, 11, pp.349~ (2020)
- Trounson A, "Stem cell therapies in clinical trials : progress and challenges", Cell Stem Cell, 17, pp.11~22 (2015)
- Tan SJ, "Novel applications of mesenchymal stem cellderived exosomes for myocardial infarction therapeutics", Biomolecules, 10, pp.707~ (2020)
- Adamiak M, "Induced pluripotent stem cell(iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs", Circ Res, 122, pp.296~309 (2018)
- Riazifar M, "Stem cell extracellular vesicles : extended messages of regeneration", Annu Rev Pharmacol Toxicol, 57, pp.125~154 (2017)
- Davidson SM, "Exosomes and cardioprotection-a critical analysis", Mol Aspects Med, 60, pp.104~114 (2018)
- Teng X, "Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation", Cell Physiol Biochem, 37, pp.2415~2424 (2015)
- Liu L, "Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia", reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt pathways, 2017, pp.43, 52~68
- Bhome R, "Exosomal microRNAs(exomiRs) : small molecules with a big role in cancer", Cancer Lett, 420, pp.228~235 (2018)
- Frangogiannis NG, "Inflammation in cardiac injury, repair and regeneration", Curr Opin Cardiol, 30, pp.240~245 (2015)
- Chong AJ, "Toll-like receptor 4 mediates ischemia", reperfusion injury of the heart, 2004, pp.128, 170~179